TECHWIRE 30
(CIX: WRAL30)  917.87  down arrow-0.81  (-0.09 %)  Updated: 12:08 PM EDT, May 24 2013
(NQ: Apple)  444.82  up arrow+2.68  (0.61 %)  Updated: 12:09 PM EDT, May 24 2013
(NY: Quintiles)  44.95  down arrow-0.05  (-0.11 %)  Updated: 12:05 PM EDT, May 24 2013
(OP: BASF SE)  94.86  down arrow-1.29  (-1.34 %)  Updated: 12:03 PM EDT, May 24 2013
(NQ: BioCryst)  1.60  down arrow-0.06  (-3.61 %)  Updated: 12:08 PM EDT, May 24 2013
(NQ: BioDelivery)  4.42  down arrow-0.08  (-1.78 %)  Updated: 12:07 PM EDT, May 24 2013
(NQ: CEMP)  6.90  up arrow+0.02  (0.29 %)  Updated: 11:45 AM EDT, May 24 2013
(NQ: Cisco Systems)  23.60  up arrow+0.09  (0.36 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: Cornerstone)  8.22  down arrow-0.19  (-2.26 %)  Updated: 11:56 AM EDT, May 24 2013
(NQ: Cree)  59.33  down arrow-1.35  (-2.23 %)  Updated: 12:08 PM EDT, May 24 2013
(NQ: DARA)  0.73  down arrow-0.02  (-2.53 %)  Updated: 11:59 AM EDT, May 24 2013
(NY: EMC Corp.)  23.55  down arrow-0.11  (-0.46 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: Extreme Networks)  3.48  up arrow+0.06  (1.78 %)  Updated: 12:07 PM EDT, May 24 2013
(NQ: Facebook)  24.40  down arrow-0.67  (-2.65 %)  Updated: 12:09 PM EDT, May 24 2013
(NY: GlaxoSmithKline)  52.89  up arrow+0.16  (0.31 %)  Updated: 12:08 PM EDT, May 24 2013
(NQ: Google)  875.14  down arrow-7.65  (-0.87 %)  Updated: 12:08 PM EDT, May 24 2013
(NY: IBM)  206.03  down arrow-0.13  (-0.06 %)  Updated: 12:08 PM EDT, May 24 2013
(NY: LH)  99.97  down arrow-0.74  (-0.73 %)  Updated: 12:08 PM EDT, May 24 2013
(OP: Lenovo Group)  19.87  up arrow+0.59  (3.06 %)  Updated: 12:01 PM EDT, May 24 2013
(NY: MRK)  46.88  down arrow-0.45  (-0.95 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: Microsoft Corp)  34.21  up arrow+0.06  (0.16 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: NetApp)  36.41  down arrow-0.49  (-1.31 %)  Updated: 12:08 PM EDT, May 24 2013
(NY: Novartis AG ADS)  74.06  up arrow+0.24  (0.33 %)  Updated: 12:08 PM EDT, May 24 2013
(OP: Novozymes A/S)  35.42  up arrow+0.32  (0.91 %)  Updated: 11:47 AM EDT, May 24 2013
(NY: Pfizer)  29.05  down arrow-0.06  (-0.21 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: Pozen)  4.99  up arrow+0.06  (1.21 %)  Updated: 12:08 PM EDT, May 24 2013
(NY: Red Hat)  48.64  down arrow-0.73  (-1.47 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: BBRY)  14.43    (0 %)  Updated: 12:09 PM EDT, May 24 2013
(NQ: Salix)  60.20  up arrow+0.51  (0.85 %)  Updated: 12:08 PM EDT, May 24 2013
(NQ: SQI)  23.75  up arrow+0.38  (1.63 %)  Updated: 12:06 PM EDT, May 24 2013

Posts tagged “Intersouth”

Updated January 20, 2012

Premium Lock North Carolina venture deals sluggish in '11 but VCs remain upbeat

Deal making totaled only $325 million across 47 deals, the lowest total since 2005 when one excludes the recession year of 2009. Life science deals dominate the fourth quarter.

Transenterix landed $15M in 4Q for its Spider surgical system Transenterix landed $15M in 4Q for its Spider surgical system

Updated January 16, 2012

Premium Lock NC-based Cempra Pharmaceuticals aims to raise $89.7M in public offering

The Chapel Hill-based company wants to sell 6 million shares at a price between $11 and $13 a share. Its underwriters have the right to sell another 900,000 shares.

Cempra Cempra

Updated December 15, 2011

Premium Lock TransEnterix CEO has 'great expectations' for new $15M in funding

Investors in the Research Triangle Park-based medical device company include Aisling Capital, Intersouth Partners, Quaker Partners, SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors.

Transenterix landed $15M in 4Q for its Spider surgical system Transenterix landed $15M in 4Q for its Spider surgical system

November 14, 2011

Premium Lock Intersouth leads $4.5M investment in electronic health records provider

Electronic medical records SimplifyMD, a Georgia-based firm, also names a former McKesson executive as its president. As part of the deal, Intersouth's John Glushnik joins the startup's board.

October 13, 2011

Premium Lock Cempra Pharmaceuticals files plans for $86M IPO

Antibiotics research Cempra does not yet have any Food and Drug Administration-approved products. Its compounds are targeting an antibiotics market that according to Datamonitor totaled $19.6 billion in the United States, Japan and the five major European markets in 2009.

September 20, 2011

Premium Lock Charlotte IT firm raises $6M, adds Red Hat exec to board

Adaptivity raises funds from Intersouth Partners, Noro-Moseley Partners and Intel Capital. The software firm also names a new chief technology officer.

Click here to open the YouTube video in a new window.

September 20, 2011

Premium Lock Cancer diagnostics startup raises $250,000

Dr. Myla Lai-Goldman GeneCentric Dianostics, which is based in Durham, is led by Hatteras Venture Partners' Myla Lai-Goldman.

September 7, 2011

Premium Lock Frey back in executive saddle as EvoApp CEO

Kip Frey Kip Frey, who left Zenph Sound Innovations last month, is the new CEO at EvoApp.

Updated August 22, 2011

Premium Lock Raleigh 'cloud' startup raises $7M, plans 5-10 new hires

6fusion, which is backed by Intersouth partners, lands a new investor in raising its second investment round.

6fusion's "Cube" concept for managing the "cloud" 6fusion's "Cube" concept for managing the "cloud"

August 19, 2011

Premium Lock Semiconductor firm Nitronex raises $2M in debt offering

Nitronex The Durham-based company hopes to raise another $3.5 million, according to an SEC filing.

Updated August 17, 2011

Premium Lock Startup Cempra Pharmaceuticals raises $5M in new capital

Cempra The Chapel Hill-based company has two clinical stage antibacterial compounds; one of which is being developed to fight nasty skin infections.

Updated August 15, 2011

Premium Lock Well-known VC Kip Frey steps down as Zenph Sound CEO

Longtime Triangle venture capitalist and entrepreneur Kip Frey resigned Friday as chief executive of Durham-based music technology company Zenph Sound Innovations.

John Walker prepares for a concert. John Walker prepares for a concert.

August 8, 2011

Premium Lock Venture-backed Cempra explores funding options

Antibiotics research The Chapel Hill firm is developing potential antibacterial drugs to combat superbugs. Will it seek more venture funding or a partnership with a bigger pharmaceutical firm?

August 5, 2011

Premium Lock Semiconductor firm HexaTech closes on $3.1M, wants another $1.1M

HexaTech The venture capital backed startup, which has been funded locally by Intersouth Partners and NCIDEA, is commercializing technology developed at NC State.

Updated July 29, 2011

Premium Lock Argos Therapeutics files for $86M initial public offering

The Durham-based biopharmaceutical firm focuses on individualized therapies targeting cancer, HIV and infectious diseases. Its investors include Intersouth Partners and Aurora Funds.

Argos process Argos process

Updated July 19, 2011

Premium Lock Semprius to build plant, create 256 jobs in Henderson

Semprius logo The Durham-based semiconductor startup will receive millions in local and state tax incentives if jobs targets are met.

Updated July 19, 2011

Premium Lock Durham semiconductor firm reportedly picks NC for new plant

Gov. Bev Perdue is to make a new jobs announcement Tuesday morning in Henderson. Semprius, which is backed by the CIA, could be the builder.

Semprius can "print" semiconductors on various surfaces Semprius can "print" semiconductors on various surfaces

July 12, 2011

Premium Lock Stem cell-focused Aldagen raises $1.1M in funding

The Durham-based company recently withdrew plans for an $80 million stock offering.

A purified STEM cell A purified STEM cell

June 30, 2011

Premium Lock CIA pours more money into Durham solar tech startup

The secret sauce at Semprius draws more money from the "Wizards of Langley" venture arm as well as Siemens and Durham-based Intersouth in its latest $20 million capital fund raiser. So what can the CIA do with advanced solar power?

Might Semprius someday power a CIA drone? Might Semprius someday power a CIA drone?

June 24, 2011

Premium Lock Solar power startup Semprius raises $20M, looks for $10M more

The Durham-based company, which recently sold a 16-percent interest to Siemens Energy, discloses the funding in a regulatory filing. It's the latest in a streak of good news for the firm and its investors, which include Durham-based Intersouth Partners.

An illustration of Semprius' transfer process An illustration of Semprius' transfer process

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Jim Roberts
Entrepreneurship
Dr. Mike Walden
Tech economy
Scroll

Videos

 
  • Allscripts bringing hundreds of jobs…

  • Nonprofit to handle NC economic…

  • Raleigh goes green, saves green with…

  • Gov. Pat McCrory speaks to NC Chamber

  • NC business leaders unveil job growth…

  • Investment expert: Leading is key in…

  • Retailers tout deals on Twitter

  • Vision for RTP: Social centerpiece